All Categories - LAV
Shanghai, China, April 10, 2025 – Belief BioMed ("BBM") and Takeda China today jointly announced...
BEIJING, March 21, 2025 /PRNewswire/ -- Syneron Bio, a cutting-edge oral macrocyclic peptide drug...
SHANGHAI, January 16th, 2025 - IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company...
2025年1月13日
[January 13, 2025] – Cornerstone Robotics (the “Company”), a leading global innovator in surgical...
2025年1月7日
January 7, 2025, Alebund Pharmaceuticals (“Alebund” or the “Company”), an integrated...
MIAMI--(BUSINESS WIRE)--Xcovery Holdings, Inc., an oncology focused pharmaceutical company, today...
December 11, 2024, Sperogenix Therapeutics announced that, AGAMREE® (vamorolone) was approved by...
PRINCETON, N.J., SHANGHAI and SUZHOU, China, Dec. 3, 2024 /PRNewswire/ -- Duality Biologics (...
SHANGHAI, November 15th, 2024 - IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company...
2024年10月29日
CMG1A46 is an investigational T cell-engager with potential to deeply deplete uncontrolled B...
Cambridge, Massachusetts, September 30, 2024 - Regor Pharmaceuticals (USA) ("Regor") has entered...
Shanghai, China and Dallas, TX, August 01, 2024 – ImmuneOnco Biopharmaceuticals (Shanghai) Inc. ...
- Financing led by LongRiver Investments with participation by new and existing global...
- Global license agreement to focus on the development of FG-M701, a TL1A antibody, for the...
Acquisition advances Johnson & Johnson’s leading Dermatology portfolio with opportunity to...
On May 15, 2024, the internationally renowned medical journal Nature Medicine (Latest impact...
SHANGHAI, April 19th, 2024 - IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company...
Genmab to acquire ProfoundBio for USD 1.8 billion in cashAcquisition will give Genmab...
March 26, 2024, the NDA filling of AGAMREE (vamorolone) is indicated for the treatment of...
Recently, Scivita Medical Technology Co., Ltd. (“Scivita Medical”) and Boston Scientific...